beta

APHB

AmpliPhi Biosciences Corporation

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Ampliphi Biosciences Corp is a biotechnology company engaged in the discovery, development and commercialization of novel phage therapeutics. The Company's pipeline is based on the use of bacteriophages.

Market Cap: 14.7 Million

Primary Exchange: NYSE American

Website: http://www.ampliphibio.com

Shares Outstanding: 13.5 Million

Float: 13 Million

Dividend: 0.0 (0.0%)

Beta: 3.189582

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 2423 trading days

From: 2013-07-24 To: 2019-05-09

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-04-25 10.0 1.0 10.0
2015-08-07 50.0 1.0 50.0
Data provided by IEX Cloud